BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12680187)

  • 21. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.
    Munoz R; Man S; Shaked Y; Lee CR; Wong J; Francia G; Kerbel RS
    Cancer Res; 2006 Apr; 66(7):3386-91. PubMed ID: 16585158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effect of a splenic injection of 5-fluorouracil on metastatic liver cancer in mice.
    Kanoh K; Shimura T; Suzuki H; Nomoto K; Asao T; Kuwano H
    J Pharmacol Exp Ther; 2004 Jan; 308(1):168-74. PubMed ID: 14569073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW; von Borstel R
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
    Kojima Y; Honda K; Hamada H; Kobayashi N
    J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
    Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
    Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visualizing portal vein metastatic trafficking to the liver with green fluorescent protein-expressing tumor cells.
    Wang J; Yang M; Hoffman RM
    Anticancer Res; 2004; 24(6):3699-702. PubMed ID: 15736399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
    Nakata E; Fukushima M; Takai Y; Nemoto K; Ogawa Y; Nomiya T; Nakamura Y; Milas L; Yamada S
    Oncol Rep; 2006 Sep; 16(3):465-71. PubMed ID: 16865244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-body subcellular multicolor imaging of tumor-host interaction and drug response in real time.
    Yang M; Jiang P; Hoffman RM
    Cancer Res; 2007 Jun; 67(11):5195-200. PubMed ID: 17545599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
    Bouvet M; Tsuji K; Yang M; Jiang P; Moossa AR; Hoffman RM
    Cancer Res; 2006 Dec; 66(23):11293-7. PubMed ID: 17145875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
    Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioluminescent imaging of hepatocellular carcinoma in live mice.
    Wang Y; Sun Z; Peng J; Zhan L
    Biotechnol Lett; 2007 Nov; 29(11):1665-70. PubMed ID: 17609854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.
    Koyama F; Fujii H; Mukogawa T; Ueno M; Hamada H; Ishikawa H; Doi S; Nakao T; Matsumoto H; Shimatani H; Takeuchi T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1343-8. PubMed ID: 12820392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice.
    Tsuji K; Yang M; Jiang P; Maitra A; Kaushal S; Yamauchi K; Katz MH; Moossa AR; Hoffman RM; Bouvet M
    JOP; 2006 Mar; 7(2):193-9. PubMed ID: 16525203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates.
    Yuan F; Qin X; Zhou D; Xiang QY; Wang MT; Zhang ZR; Huang Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):770-6. PubMed ID: 18656539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer.
    Howard EW; Ling MT; Chua CW; Cheung HW; Wang X; Wong YC
    Clin Cancer Res; 2007 Mar; 13(6):1847-56. PubMed ID: 17363541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG; Macció DR; Lopez MV; Viale DL; Carbone C; Mazzolini G; Podhajcer OL
    Clin Cancer Res; 2009 May; 15(9):3037-49. PubMed ID: 19336523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
    Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ
    Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.